ST. PAUL, Minn.–(BUSINESS WIRE)–Ecolab Inc., the global leader in water, hygiene and energy technologies
and services, has made an offer to acquire Bioquell PLC (LSE: BQE), a
leading provider of hydrogen peroxide vapor bio-decontamination systems
and services for the life sciences and healthcare industries.
Headquartered in Andover, U.K., Bioquell’s 2017 sales were approximately
£29 million ($37 million).
Bioquell’s innovative bio-decontamination and isolator technologies and
services help ensure residue-free surface decontamination in cleanrooms
and research and development labs at biotech start-ups, pharmaceutical
manufacturers and Fortune 500 companies, and in patient rooms at
hospitals in more than 50 countries.
Under the terms of Ecolab’s offer, Bioquell shareholders will receive
590 pence per share. Additional information on the transaction is
available in the firm offer announcement, which can be found at investor.ecolab.com.
The transaction, if approved by Bioquell shareholders, is expected to
close in the first quarter of 2019, subject to satisfaction of customary
closing conditions and regulatory clearance.
A trusted partner at nearly three million customer locations, Ecolab
(ECL) is the global leader in water, hygiene and energy technologies and
services that protect people and vital resources. With annual sales of
$14 billion and 48,000 associates, Ecolab delivers comprehensive
solutions, data-driven insights and on-site service to promote safe
food, maintain clean environments, optimize water and energy use, and
improve operational efficiencies for customers in the food, healthcare,
energy, hospitality and industrial markets in more than 170 countries
around the world.
In accordance with Rule 2.11 of the UK Takeover Code, we refer to you
the announcement released by Ecolab Inc. and Bioquell PLC on 30 November
2018 that the board of directors of Ecolab Inc. and Bioquell PLC have
jointly agreed to the terms of a recommended cash offer for Bioquell
pursuant to which Ecolab U.S. 2 Inc. will acquire the entire issued and
to be issued share capital of Bioquell PLC. A copy of the announcement
will be published on Ecolab’s website at investor.ecolab.com
no later than 12 p.m. London time on 3 December 2018.